[ad_1]
WWhat will happen to Celgene (CELG) if the proposed $ 74 billion acquisition by Bristol-Myers Squibb (BMY) dies?
"It would be a total nightmare, a pessimistic scenario for Celgene.The members of his board of directors are currently doing everything in their power to prevent any transaction activist hedge fund.
Unlock this item by subscribing to STAT Plus and enjoy your first 30 days for free!
TO START
What is it?
STAT Plus is a premium subscription that offers scalable biopharmaceutical market coverage and in-depth scientific reports from a team with several decades of experience in the industry.
What is included?
- Authoritative coverage and biopharmaceutical analysis, interviews with industry pioneers, policy analysis and first examination of advanced laboratories and early stage research
- Subscriber Networking Events and Group Discussions Across the Country
- Monthly live subscriber discussions with our reporters and experts in the field
- Discounted tickets for industry events and early access to industry reports
[ad_2]
Source link